Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6


Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague.

Williamson ED, Packer PJ, Waters EL, Simpson AJ, Dyer D, Hartings J, Twenhafel N, Pitt ML.

Vaccine. 2011 Jun 24;29(29-30):4771-7. doi: 10.1016/j.vaccine.2011.04.084. Epub 2011 May 12.


Repertoire of HLA-DR1-restricted CD4 T-cell responses to capsular Caf1 antigen of Yersinia pestis in human leukocyte antigen transgenic mice.

Musson JA, Ingram R, Durand G, Ascough S, Waters EL, Hartley MG, Robson T, Maillere B, Williamson ED, Sriskandan S, Altmann D, Robinson JH.

Infect Immun. 2010 Oct;78(10):4356-62. doi: 10.1128/IAI.00195-10. Epub 2010 Jul 26.


Human immune response to a plague vaccine comprising recombinant F1 and V antigens.

Williamson ED, Flick-Smith HC, Lebutt C, Rowland CA, Jones SM, Waters EL, Gwyther RJ, Miller J, Packer PJ, Irving M.

Infect Immun. 2005 Jun;73(6):3598-608.


Mouse model characterisation for anthrax vaccine development: comparison of one inbred and one outbred mouse strain.

Flick-Smith HC, Waters EL, Walker NJ, Miller J, Stagg AJ, Green M, Williamson ED.

Microb Pathog. 2005 Jan;38(1):33-40. Epub 2004 Dec 19.


Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice.

Flick-Smith HC, Eyles JE, Hebdon R, Waters EL, Beedham RJ, Stagg TJ, Miller J, Alpar HO, Baillie LW, Williamson ED.

Infect Immun. 2002 Apr;70(4):2022-8.


Immune tolerance therapy for haemophilia A patients with acquired factor VIII alloantibodies: comprehensive analysis of experience at a single institution.

Smith MP, Spence KJ, Waters EL, Beresford-Webb R, Mitchell MJ, Cuttler J, Alhaq A, Brown SA, Savidge GF.

Thromb Haemost. 1999 Jan;81(1):35-8.


Supplemental Content

Loading ...
Support Center